🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/05/2015 | 182,58 | 186,02 | 181,67 | 183,69 | +0,59% | 2,38% | 381.800 |
| 21/05/2015 | 183,48 | 184,38 | 181,17 | 182,61 | -0,10% | 1,75% | 442.500 |
| 20/05/2015 | 178,89 | 185,49 | 178,62 | 182,80 | +2,66% | 3,84% | 690.000 |
| 19/05/2015 | 180,86 | 180,86 | 177,63 | 178,06 | -0,69% | 1,79% | 371.000 |
| 18/05/2015 | 174,73 | 180,03 | 173,07 | 179,30 | +3,79% | 3,98% | 623.500 |
| 15/05/2015 | 173,79 | 174,64 | 171,87 | 172,75 | -0,45% | 1,59% | 437.900 |
| 14/05/2015 | 176,96 | 176,96 | 173,19 | 173,53 | -1,11% | 2,13% | 666.100 |
| 13/05/2015 | 174,63 | 177,79 | 173,52 | 175,47 | +1,19% | 2,45% | 550.800 |
| 12/05/2015 | 176,58 | 177,61 | 173,03 | 173,41 | -3,27% | 2,59% | 615.500 |
| 11/05/2015 | 178,48 | 180,96 | 177,36 | 179,28 | +0,21% | 2,02% | 558.000 |
| 08/05/2015 | 174,46 | 179,52 | 174,37 | 178,91 | +3,61% | 2,95% | 744.400 |
| 07/05/2015 | 167,94 | 174,45 | 164,78 | 172,68 | +2,77% | 5,76% | 806.500 |
| 06/05/2015 | 170,20 | 173,36 | 166,00 | 168,02 | -1,02% | 4,32% | 554.000 |
| 05/05/2015 | 169,70 | 171,45 | 168,60 | 169,76 | +0,14% | 1,68% | 663.200 |
| 04/05/2015 | 170,07 | 172,34 | 167,92 | 169,52 | -0,82% | 2,60% | 965.000 |
| 01/05/2015 | 161,38 | 173,70 | 157,20 | 170,92 | +7,03% | 10,22% | 1.009.800 |
| 30/04/2015 | 163,90 | 164,80 | 157,76 | 159,69 | -3,04% | 4,30% | 868.200 |
| 29/04/2015 | 163,24 | 166,96 | 161,01 | 164,69 | +0,85% | 3,64% | 798.700 |
| 28/04/2015 | 168,00 | 174,75 | 159,37 | 163,31 | -5,17% | 9,15% | 2.352.800 |
| 27/04/2015 | 186,79 | 188,19 | 170,31 | 172,22 | -7,75% | 9,57% | 1.268.200 |
| 24/04/2015 | 188,56 | 189,00 | 186,57 | 186,69 | -0,99% | 1,29% | 409.200 |
| 23/04/2015 | 187,50 | 189,12 | 184,88 | 188,56 | +0,31% | 2,26% | 647.800 |
| 22/04/2015 | 188,65 | 188,92 | 184,50 | 187,98 | +0,06% | 2,34% | 538.100 |
| 21/04/2015 | 185,80 | 188,78 | 183,67 | 187,86 | +1,37% | 2,75% | 707.000 |
| 20/04/2015 | 185,93 | 186,48 | 182,80 | 185,33 | +0,08% | 1,98% | 453.600 |
| 17/04/2015 | 187,03 | 187,13 | 182,04 | 185,19 | -1,45% | 2,72% | 615.900 |
| 16/04/2015 | 185,78 | 190,29 | 184,88 | 187,91 | +1,59% | 2,91% | 654.200 |
| 15/04/2015 | 185,85 | 187,29 | 183,16 | 184,97 | -0,46% | 2,22% | 563.000 |
| 14/04/2015 | 186,63 | 188,09 | 183,31 | 185,82 | -0,55% | 2,56% | 733.400 |
| 13/04/2015 | 184,50 | 189,16 | 184,50 | 186,84 | +1,30% | 2,53% | 587.800 |